Search

The finalists for the ACES Academic Enterprise Award were selected at a meeting on 5 November at University College London. Here are the participants.

There could be no more graphic and endearing image of the potential that stem cell research has to replace damaged or diseased tissue - and treat the previously untreatable - than the picture of the smiling, happy and restored Claudia Castillo, after a windpipe transplant.

Healthcare is unreceptive to technology because it still operates under a 19th-century business model. It’s time for its organisation and systems to change.

Two years after reforming its R&D process, pharma giant Novartis says it has seen a 40 per cent increase in productivity.

With the capital markets closed, partnering is currently the only way for development–stage biotechs to stay in business.